EUTM file information

018612841

C-srRNA


November 30, 2021

Trademark Summary

The trademark application c-srRNA was filed by Elixirgen Therapeutics, Inc, a U.S. corporation (the "Applicant"). The application was published for oppositions on February 27, 2022, and it was registered by office on June 6, 2022 without any oppositions.

The application was filed in Dutch (English was selected as the second language).

Change of name and professional address of the trademark registration was recorded on September 18, 2023.


Goods And Services

  • The mark was filed in class 5 with Vaccines.
  • The mark was filed in class 44 with following description of goods:
    1. Gene therapy
    2. Cell therapy
    3. Regenerative medicine.